Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Fibronectin

Fibronectin

Brief Information

Name:Fibronectin
Target Synonym:Epididymis Secretory Sperm Binding Protein,Migration-Stimulating Factor,CIG,GFND2,SMDCF,ED-B,FINC,GFND,LETS,FNZ,MSF,Fibronectins,FN,FN1,Fibronectin,Fibronectin 1,Cold-Insoluble Globulin
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:7
Lastest Research Phase:Approved

Product ListCompare or Buy

ACRO Quality

Part of Bioactivity data

GMP-FINH18-SPR
 Fibronectin SPR

Biotinylated Human ITGA4&ITGB1 Heterodimer Protein, His,Avitag&Tag Free (Cat. No. IT1-H82W1) immobilized on SA Chip can bind GMP Recombinant Human Fibronectin fragment (Cat. No. GMP-FINH18) with a typical affinity constant of 0.799 μM as determined in a SPR assay (Biacore 8K) (QC tested).

GMP-FINH18-SPR
 Fibronectin SPR

Biotinylated Human ITGA5&ITGB1 Heterodimer Protein, His,Avitag&Tag Free (Cat. No. IT1-H82Wa) immobilized on SA Chip can bind GMP Recombinant Human Fibronectin fragment (Cat. No. GMP-FINH18) with a typical affinity constant of 35.7 nM as determined in a SPR assay (Biacore 8K) (QC tested).

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Ocriplasmin A-01016; THR-409 Approved Thrombogenics Jetrea, Jejetrea United States Vitreomacular Adhesion Thrombogenics Inc 2012-10-17 Vitreous Detachment; Arterial Occlusive Diseases; Disease Progression; Stroke; Retinal Diseases; Diabetic macular oedema; Uveitis; Vitreomacular Adhesion; Eye Diseases; Venous Thrombosis; Macular Degeneration; Diabetic Retinopathy; Retinal Vein Occlusion Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Onfekafusp alfa Phase 3 Clinical Philogen Spa Solid tumours; Glioblastoma; Sarcoma; Breast Neoplasms; Genital Neoplasms, Female; Colorectal Neoplasms; Glioma; Lung Neoplasms; Melanoma Details
Darleukin/fibromun L19-IL-2/ L19-TNF-α Phase 3 Clinical Philogen Spa Carcinoma, Merkel Cell; Carcinoma, Basal Cell; Carcinoma, Skin Appendage; Keratoacanthoma; Basal Cell Nevus Syndrome; Carcinoma, Squamous Cell; Lymphoma, T-Cell, Cutaneous; Melanoma; Sarcoma, Kaposi Details
Bifikafusp alfa L19-IL-2 Phase 3 Clinical Philogen Spa Solid tumours; Adenomatous Polyposis Coli; Pancreatic Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung Details
Radretumab L19-I131; L19-SIP; I-L19-SIP; I-131-L19-SIP; 131I-L19-SIP; L19-131-I; 131I-radretumab; 131I-L19SIP; L19-131I Phase 2 Clinical Philogen Spa Hematologic Neoplasms; Hodgkin Disease; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung Details
PYX-201 PYX-201 Phase 2 Clinical Pfizer Inc Solid tumours Details
F8-IL10 F8-IL10; PF-06687234 Phase 2 Clinical Philogen Spa Inflammatory Bowel Diseases; Arthritis, Rheumatoid; Colitis, Ulcerative Details
177Lu-B5-IgG4 177-Lu-B5-IgG4 Phase 1 Clinical Affiliated Hospital of Jiangnan University Solid tumours Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message